Top Key Companies for Diagnostic Imaging Agent Market: GE HealthCare, Bracco Diagnostic, Guerbet, Mallinckrodt, Lantheus, Yantai Dongcheng, Foshan Rui Diao Pharmaceutical, Cardinal Health, Blue Earth Diagnostics, Bayer AG, Abx Advanced Biochemical, Eli Lilly and Company, Jubilant Pharma Limited, Navidea.
Global Diagnostic Imaging Agent Market Size was estimated at USD 879 million in 2022 and is projected to reach USD 985.25 million by 2028, exhibiting a CAGR of 1.92% during the forecast period.
Global Diagnostic Imaging Agent Market Overview And Scope:
The Global Diagnostic Imaging Agent Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Diagnostic Imaging Agent utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Diagnostic Imaging Agent Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Diagnostic Imaging Agent portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Diagnostic Imaging Agent market.
Global Diagnostic Imaging Agent Market Segmentation
By Type, Diagnostic Imaging Agent market has been segmented into:
Conjugated Imaging Agent
Metabolic Imaging Agent
Blood Flow and Blood Volume Imaging Agents
By Application, Diagnostic Imaging Agent market has been segmented into:
Tumor
Heart Disease
Gastrointestinal Disease
Neurological Disease
Regional Analysis of Diagnostic Imaging Agent Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Diagnostic Imaging Agent Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Diagnostic Imaging Agent market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Diagnostic Imaging Agent market.
Top Key Companies Covered in Diagnostic Imaging Agent market are:
GE HealthCare
Bracco Diagnostic
Guerbet
Mallinckrodt
Lantheus
Yantai Dongcheng
Foshan Rui Diao Pharmaceutical
Cardinal Health
Blue Earth Diagnostics
Bayer AG
Abx Advanced Biochemical
Eli Lilly and Company
Jubilant Pharma Limited
Navidea
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Diagnostic Imaging Agent Market by Type
5.1 Diagnostic Imaging Agent Market Overview Snapshot and Growth Engine
5.2 Diagnostic Imaging Agent Market Overview
5.3 Conjugated Imaging Agent
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Conjugated Imaging Agent: Geographic Segmentation
5.4 Metabolic Imaging Agent
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Metabolic Imaging Agent: Geographic Segmentation
5.5 Blood Flow and Blood Volume Imaging Agents
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Blood Flow and Blood Volume Imaging Agents: Geographic Segmentation
Chapter 6: Diagnostic Imaging Agent Market by Application
6.1 Diagnostic Imaging Agent Market Overview Snapshot and Growth Engine
6.2 Diagnostic Imaging Agent Market Overview
6.3 Tumor
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Tumor: Geographic Segmentation
6.4 Heart Disease
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Heart Disease: Geographic Segmentation
6.5 Gastrointestinal Disease
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Gastrointestinal Disease: Geographic Segmentation
6.6 Neurological Disease
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Neurological Disease: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Diagnostic Imaging Agent Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Diagnostic Imaging Agent Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Diagnostic Imaging Agent Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 GE HEALTHCARE
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 BRACCO DIAGNOSTIC
7.4 GUERBET
7.5 MALLINCKRODT
7.6 LANTHEUS
7.7 YANTAI DONGCHENG
7.8 FOSHAN RUI DIAO PHARMACEUTICAL
7.9 CARDINAL HEALTH
7.10 BLUE EARTH DIAGNOSTICS
7.11 BAYER AG
7.12 ABX ADVANCED BIOCHEMICAL
7.13 ELI LILLY AND COMPANY
7.14 JUBILANT PHARMA LIMITED
7.15 NAVIDEA
Chapter 8: Global Diagnostic Imaging Agent Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Conjugated Imaging Agent
8.2.2 Metabolic Imaging Agent
8.2.3 Blood Flow and Blood Volume Imaging Agents
8.3 Historic and Forecasted Market Size By Application
8.3.1 Tumor
8.3.2 Heart Disease
8.3.3 Gastrointestinal Disease
8.3.4 Neurological Disease
Chapter 9: North America Diagnostic Imaging Agent Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Conjugated Imaging Agent
9.4.2 Metabolic Imaging Agent
9.4.3 Blood Flow and Blood Volume Imaging Agents
9.5 Historic and Forecasted Market Size By Application
9.5.1 Tumor
9.5.2 Heart Disease
9.5.3 Gastrointestinal Disease
9.5.4 Neurological Disease
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Diagnostic Imaging Agent Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Conjugated Imaging Agent
10.4.2 Metabolic Imaging Agent
10.4.3 Blood Flow and Blood Volume Imaging Agents
10.5 Historic and Forecasted Market Size By Application
10.5.1 Tumor
10.5.2 Heart Disease
10.5.3 Gastrointestinal Disease
10.5.4 Neurological Disease
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Diagnostic Imaging Agent Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Conjugated Imaging Agent
11.4.2 Metabolic Imaging Agent
11.4.3 Blood Flow and Blood Volume Imaging Agents
11.5 Historic and Forecasted Market Size By Application
11.5.1 Tumor
11.5.2 Heart Disease
11.5.3 Gastrointestinal Disease
11.5.4 Neurological Disease
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Diagnostic Imaging Agent Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Conjugated Imaging Agent
12.4.2 Metabolic Imaging Agent
12.4.3 Blood Flow and Blood Volume Imaging Agents
12.5 Historic and Forecasted Market Size By Application
12.5.1 Tumor
12.5.2 Heart Disease
12.5.3 Gastrointestinal Disease
12.5.4 Neurological Disease
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Diagnostic Imaging Agent Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Conjugated Imaging Agent
13.4.2 Metabolic Imaging Agent
13.4.3 Blood Flow and Blood Volume Imaging Agents
13.5 Historic and Forecasted Market Size By Application
13.5.1 Tumor
13.5.2 Heart Disease
13.5.3 Gastrointestinal Disease
13.5.4 Neurological Disease
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Diagnostic Imaging Agent Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Conjugated Imaging Agent
14.4.2 Metabolic Imaging Agent
14.4.3 Blood Flow and Blood Volume Imaging Agents
14.5 Historic and Forecasted Market Size By Application
14.5.1 Tumor
14.5.2 Heart Disease
14.5.3 Gastrointestinal Disease
14.5.4 Neurological Disease
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Diagnostic Imaging Agent Scope:
|
Report Data
|
Diagnostic Imaging Agent Market
|
|
Diagnostic Imaging Agent Market Size in 2025
|
USD XX million
|
|
Diagnostic Imaging Agent CAGR 2025 - 2032
|
XX%
|
|
Diagnostic Imaging Agent Base Year
|
2024
|
|
Diagnostic Imaging Agent Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
GE HealthCare, Bracco Diagnostic, Guerbet, Mallinckrodt, Lantheus, Yantai Dongcheng, Foshan Rui Diao Pharmaceutical, Cardinal Health, Blue Earth Diagnostics, Bayer AG, Abx Advanced Biochemical, Eli Lilly and Company, Jubilant Pharma Limited, Navidea.
|
|
Key Segments
|
By Type
Conjugated Imaging Agent
Metabolic Imaging Agent
Blood Flow and Blood Volume Imaging Agents
By Applications
Tumor
Heart Disease
Gastrointestinal Disease
Neurological Disease
|
